Telehealth Effectively Diagnoses / Manages Fetal Congenital Heart Disease in Rural Patients

A recent study of 368 pregnant mothers, led by Bettina Cuneo, MD, director of perinatal cardiology and fetal cardiac telemedicine at Children's Hospital Colorado, found that fetal congenital heart disease (CHD) was correctly identified and successfully managed according to evidence-based risk stratification. In addition, parents achieved a dramatic cost benefit and patient/physician satisfaction was high.

This study, which was performed in conjuiction with St. Mary's Maternal Fetal Medicine and OBGYN Clinic, which is about 250 miles and two mountain passes away from the Children's Hospital Colorado's Heart Institute, is the first to look at the effects of a telecardiology program on the detection and risk stratification of fetal CHD in a medically underserved area. The program used real-time video consultation between medical experts in the clinic and pediatric cardiologists at Children's Hospital Colorado.

"With these findings, we can now confidently say that neither diagnostic quality nor patient satisfaction were sacrificed with telecardiology as opposed to in-person visits," said Dr. Cuneo. "The study also suggests that a telecardiology program is feasible and has economic advantages for the parents while keeping care close to home."

Specific findings include:

  • Obstetric sonographers who participated in the study improved their identification of fetal CHD;
  • Mothers who are carrying a fetus with suspected CHD were seen the same day even if outside the virtual clinic hours;
  • All mothers preferred their fetal cardiac evaluation to take place locally rather than traveling to the distant center;
  • The estimated total cost to parents for fetal cardiac evaluation at the distant center was 10-times greater than that of telecardiology; and
  • 100% of pregnancies with fetal CHD were correctly risk stratified

CHD is the most common birth defect and a significant cause of perinatal morbidity and mortality. Prenatal diagnosis of CHD helps ensure the optimal delivery site for the mother and baby. For example, a fetus identified with CHD that requires immediate intervention may benefit from delivery at a cardiac center of excellence, while those with stable CHD may safely deliver at a community hospital. This anticipatory care improves postnatal outcomes and effectively utilizes medical resources by delivering low-risk fetuses locally.

"While 90% of pregnant women in the United States receive at least one ultrasound during their pregnancy, fewer than 50% of infants with CHD requiring immediate postnatal intervention are diagnosed before birth," said Dr. Cuneo. "Since the lowest CHD detection rates are in rural and medically underserved areas, we are thrilled to show that telecardiology programs can effectively diagnose and manage CHD cases in those communities."

Bettina Cuneo, Christina Olson, Caitlin Haxel, Lisa Howley, Amy Gagnon, D Benson, Alexander Kaizer, J Thomas.
Risk Stratification of Fetal Cardiac Anomalies in an Underserved Population Using Telecardiology.
Obstetrics & Gynecology. 134(5):1096–1103, NOVEMBER 2019. doi: 10.1097/AOG.0000000000003502.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...